UBS Upgrades Philip Morris Intl to Buy, Raises Price Target to $116
UBS analyst Nik Oliver upgrades Philip Morris Intl (NYSE:PM) from Neutral to Buy and raises the price target from $106 to $116.
Stifel Upgrades Kontoor Brands to Buy, Raises Price Target to $63
Stifel analyst Jim Duffy upgrades Kontoor Brands (NYSE:KTB) from Hold to Buy and raises the price target from $44 to $63.
JP Morgan Upgrades NetEase to Overweight, Raises Price Target to $100
JP Morgan analyst Daniel Chen upgrades NetEase (NASDAQ:NTES) from Neutral to Overweight and raises the price target from $85 to $100.
Argus Research Upgrades Airbnb to Buy, Announces $144 Price Target
Argus Research analyst John Staszak upgrades Airbnb (NASDAQ:ABNB) from Hold to Buy and announces $144 price target.
JP Morgan Upgrades Revolution Medicines to Overweight, Raises Price Target to $38
JP Morgan analyst Eric Joseph upgrades Revolution Medicines (NASDAQ:RVMD) from Neutral to Overweight and raises the price target from $32 to $38.
Piper Sandler Upgrades Broadmark Realty Capital to Neutral, Raises Price Target to $6
Piper Sandler analyst Crispin Love upgrades Broadmark Realty Capital (NYSE:BRMK) from Underweight to Neutral and raises the price target from $3.75 to $6.
Goldman Sachs Upgrades Krystal Biotech to Buy, Raises Price Target to $124
Goldman Sachs analyst Madhu Kumar upgrades Krystal Biotech (NASDAQ:KRYS) from Neutral to Buy and raises the price target from $79 to $124.
Analyst Says This Small Cap Biotech Firm Has ‘Very Valuable Therapeutic,’ Upgrades Stock
Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ:DYN) from Outperform to Strong Buy and raised the price target to $27 from $16.…
Willis Towers Watson Gets Upgrade From Goldman Sachs As Analyst Sees Turnaround By 2HFY23
Goldman Sachs analyst Robert Cox upgraded Willis Towers Watson (NASDAQ: WTW) from Neutral to Buy
B of A Securities Upgrades California Resources to Buy, Raises Price Target to $60
B of A Securities analyst Kalei Akamine upgrades California Resources (NYSE:CRC) from Neutral to Buy and raises the price target from $51 to $60.